Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
BMC Med Genet. 2011 Aug 9;12:106. doi: 10.1186/1471-2350-12-106.
Heterozygous copy-number and missense variants in CNTNAP2 and NRXN1 have repeatedly been associated with a wide spectrum of neuropsychiatric disorders such as developmental language and autism spectrum disorders, epilepsy and schizophrenia. Recently, homozygous or compound heterozygous defects in either gene were reported as causative for severe intellectual disability.
99 patients with severe intellectual disability and resemblance to Pitt-Hopkins syndrome and/or suspected recessive inheritance were screened for mutations in CNTNAP2 and NRXN1. Molecular karyotyping was performed in 45 patients. In 8 further patients with variable intellectual disability and heterozygous deletions in either CNTNAP2 or NRXN1, the remaining allele was sequenced.
By molecular karyotyping and mutational screening of CNTNAP2 and NRXN1 in a group of severely intellectually disabled patients we identified a heterozygous deletion in NRXN1 in one patient and heterozygous splice-site, frameshift and stop mutations in CNTNAP2 in four patients, respectively. Neither in these patients nor in eight further patients with heterozygous deletions within NRXN1 or CNTNAP2 we could identify a defect on the second allele. One deletion in NRXN1 and one deletion in CNTNAP2 occurred de novo, in another family the deletion was also identified in the mother who had learning difficulties, and in all other tested families one parent was shown to be healthy carrier of the respective deletion or mutation.
We report on patients with heterozygous defects in CNTNAP2 or NRXN1 associated with severe intellectual disability, which has only been reported for recessive defects before. These results expand the spectrum of phenotypic severity in patients with heterozygous defects in either gene. The large variability between severely affected patients and mildly affected or asymptomatic carrier parents might suggest the presence of a second hit, not necessarily located in the same gene.
CNTNAP2 和 NRXN1 中的杂合拷贝数和错义变异与广泛的神经精神疾病有关,例如发育性语言和自闭症谱系障碍、癫痫和精神分裂症。最近,这两个基因中的纯合或复合杂合缺陷被报道为严重智力障碍的致病原因。
对 99 名有严重智力障碍且与 Pitt-Hopkins 综合征和/或疑似隐性遗传相似的患者进行 CNTNAP2 和 NRXN1 基因突变筛查。对 45 名患者进行分子细胞遗传学检测。在另外 8 名智力障碍程度不同且 CNTNAP2 或 NRXN1 中存在杂合性缺失的患者中,对剩余的等位基因进行测序。
通过对一组严重智力障碍患者进行分子细胞遗传学和 CNTNAP2 和 NRXN1 的突变筛查,我们在一名患者中发现了 NRXN1 的杂合性缺失,在四名患者中分别发现了 CNTNAP2 的杂合性剪接、移码和终止突变。在这些患者以及另外 8 名 NRXN1 或 CNTNAP2 中存在杂合性缺失但未发现第二等位基因缺陷的患者中均未发现缺陷。NRXN1 中的一个缺失和 CNTNAP2 中的一个缺失是新发的,在另一个家庭中,该缺失也在有学习困难的母亲中发现,在所有其他经测试的家庭中,一个父母被证明是相应缺失或突变的健康携带者。
我们报告了 CNTNAP2 或 NRXN1 中存在杂合性缺陷与严重智力障碍相关的患者,此前仅报道过隐性缺陷与严重智力障碍相关。这些结果扩展了这两个基因中存在杂合性缺陷患者的表型严重程度谱。严重受影响的患者与轻度受影响或无症状的携带父母之间的巨大差异可能表明存在第二个打击,不一定位于同一基因中。